| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |